Stick to Lower Infusion Rates for Renal Patients Receiving Carimune NF

December 2016

You can make a big impact on the safe use of intravenous immune globulin (IVIG) products.

All IVIG comes from human donors...and products seem to be CLINICALLY equivalent. But manufacturing leads to differences in IgA amount, stabilizers, osmolality, etc...which may affect some patients.

Be aware of certain caveats.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Acute Pain Follow the Latest Thinking when Treating ACUTE Pain in Chronic Opioid Patients
Heart Failure Don't Add Tolvaptan (Samsca) to Improve Diuresis in HF Patients
Immunology Stick to Lower Infusion Rates for Renal Patients Receiving Carimune NF
Insulin Think of Basaglar as a New BRAND of Insulin Glargine...NOT a Generic for Lantus
Gout Consider a Corticosteroid Over an NSAID for Acute Gout
Pregnancy Evaluate Pregnant Women for VTE Risks on Admission
Cancer Add Non-Opioids for Bone and Neuropathic Pain in Cancer Patients
Statins Start Appropriate Diabetes Patients on a Statin
Adverse Events Document Excipient Allergies in the EHR
Diabetes Feel Comfortable Holding NON-Insulin Diabetes Meds in Type 1s
Supplements Feel Comfortable Holding Turmeric on Admission

Stick to Lower Infusion Rates for Renal Patients Receiving Carimune NF

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents